Corbion announces strong full-year 2025 results with +26.7% organic Adjusted EBITDA growth, +63.3% EPS growth, and €90.8 million in FCF; announces special dividend

Core Insights - Corbion reported strong financial results for the year ending December 31, 2025, with significant growth in sales and adjusted EBITDA, reflecting the company's effective strategies in sustainable food ingredients [1][6]. Financial Performance - Organic sales growth for 2025 was +2.2%, with Q4 showing a stronger growth of +5.4% [2]. - Total sales reached €1,267.4 million for the year, with Q4 sales at €310.2 million [2][4]. - Adjusted EBITDA for the year was €204.3 million, representing a +26.7% organic growth, with Q4 adjusted EBITDA at €48.0 million [2][4]. - Operating profit increased to €116.5 million, reflecting an organic increase of +66.1% [2][4]. - Earnings per share (EPS) rose by +63.3% to €1.29 [2]. Dividend Proposal - The company proposed a dividend distribution of €1.00 per share, which includes a regular dividend of €0.64 and a special dividend of €0.36, highlighting its commitment to shareholder returns [2][6]. Segment Performance - In the Functional Ingredients & Solutions segment, positive volume/mix contributed to sales growth, with adjusted EBITDA margins improving by +230 basis points due to cost reductions and specialty product development [7]. - The Health & Nutrition segment experienced high-single-digit percent volume/mix growth, with Q4 showing particularly strong growth of +40%. The segment maintained a full-year adjusted EBITDA margin of 32.5% [8]. Future Outlook - For FY 2026, the company anticipates organic sales growth of +3-6% and an adjusted EBITDA margin of approximately 17%, with free cash flow expected to be around €85-90 million [5].